Recombinant ITGAL (Efalizumab Biosimilar) antibody
Reactivity: Human
BR, FACS
Host: Human
Monoclonal
hu1124
unconjugated
Recombinant Antibody
1 image
-
- Target See all ITGAL (Efalizumab Biosimilar) products
- ITGAL (Efalizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
-
Clonality
- Monoclonal
-
Conjugate
- This ITGAL (Efalizumab Biosimilar) antibody is un-conjugated
- Application
- Blocking Reagent (BR), Flow Cytometry (FACS)
- Specificity
- Binds to human LFA-1.
- Characteristics
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Purification
- Purified antibody.
- Purity
- > 98 % as determined by SDS-PAGE
- Endotoxin Level
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Immunogen
- Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.
- Clone
- Hu1124
- Isotype
- IgG1 kappa
-
anti-ITGAL (Efalizumab Biosimilar) antibody
Reactivity: Human BR, FACS Host: Rabbit Monoclonal hu1124 unconjugated Recombinant Antibody
-
- Application Notes
- Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- ITGAL (Efalizumab Biosimilar)
- Abstract
- ITGAL (Efalizumab Biosimilar) Products
- Synonyms
- CD11A antibody, LFA-1 antibody, LFA1A antibody, integrin subunit alpha L antibody, ITGAL antibody
- Target Type
- Biosimilar
- Background
- LFA-1, integrin alpha L
- UniProt
- P20701
-
You are here:
